高表达线粒体转录因子A对肾癌细胞增殖和侵袭的影响

doi:10.3969/j.issn.1006-5725.2026.05.005

摘要/Abstract

摘要：

目的探讨线粒体转录因子A（TFAM）基因对肾癌细胞增殖和侵袭的影响。方法在肾癌细胞ACHN、A704中高表达TFAM，通过流式细胞仪检测细胞凋亡。在ACHN、A704中低表达TFAM，通过CCK8、流式细胞仪、侵袭、迁移实验检测细胞增殖、周期和侵袭能力。通过qPCR、Western blot检测高表达TFAM和敲低TFAM后mRNA和蛋白的变化以及CHIP-qPCR探究TFAM靶基因。结果在ACHN、A704细胞中转染入质粒后，与对照组相比TFAM表达明显增高，高表达TFAM组细胞凋亡明显减少。在ACHN、A704细胞中敲低TFAM，与对照组相比TFAM明显降低，低表达TFAM细胞增殖能力、侵袭能力较对照组明显降低。高表达TFAM肾癌细胞增殖能力增强，低表达TFAM细胞增殖侵袭能力受到抑制。TFAM能靶向调控CDC25B和CCNE2，可能通过激活CDC25B和CCNE2促进肾癌细胞的增殖。结论 TFAM能够促进肾癌细胞的增殖和侵袭。

关键词: 线粒体转录因子A, 肾癌细胞, 增殖, 侵袭

Abstract:

Objective To conduct a focused investigation on the effect of the TFAM gene on the proliferation and invasion of renal cancer cells. Methods Renal cancer cells ACHN and A704 were transfected with a plasmid for TFAM overexpression， and cell apoptosis was detected by flow cytometry. In ACHN and A704 cells， TFAM was knocked down， and cell proliferation， cell cycle， and invasion ability were assessed using CCK8， flow cytometry， invasion， and migration assays. Changes in mRNA and protein levels after TFAM overexpression and knockdown were detected by qPCR and western blot， respectively. qPCR and western blot were used to detect mRNA and protein changes after TFAM overexpression and knockdown， and ChIP-qPCR was performed to explore TFAM target genes. Results After transfection with the plasmid， ACHN and A704 cells exhibited a significant increase in TFAM expression compared to the control group， and the apoptosis of cells in the high TFAM expression group was significantly reduced. When TFAM was knocked down in ACHN and A704 cells， TFAM levels were significantly lower than those in the control group， and the proliferation and invasion abilities of cells with low TFAM expression were significantly decreased compared to the control group. High expression of TFAM enhanced the proliferation ability of renal cancer cells， while low expression of TFAM inhibited the proliferation and invasion abilities of the cells. TFAM can target and regulate CDC25B and CCNE2， and it may promote renal cancer cell proliferation by activating CDC25B and CCNE2. Conclusion TFAM can promote the proliferation and invasion of renal cancer cells.

Key words: transcription factor A, mitochondrial, renal cancer cells, proliferation, invasion

中图分类号:

R737

李环辉,邱晓拂,李高远,付钰. 高表达线粒体转录因子A对肾癌细胞增殖和侵袭的影响[J]. 实用医学杂志, 2026, 42(5): 759-767.

Huanhui LI,Xiaofu QIU,Gaoyuan LI,Yu FU. TFAM overexpression promotes the proliferation and invasion of renal cancer cells[J]. The Journal of Practical Medicine, 2026, 42(5): 759-767.

图/表 7

图1

图2

图3

图4

图5

图6

图7

参考文献 30

[1]	CHEN B， LI J， HUANG Y， et al. The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era： A systematic review and meta-analysis ［J］. Int J Surg，2023，109（4）：982-994. doi： 10.1097/JS9.0000000000000314 . doi: 10.1097/JS9.0000000000000314
[2]	陈浩，牛云峰，王琦，等. IQGAP2在肾细胞癌中的表达以及对肾癌细胞恶性生物学行为的影响［J］. 实用医学杂志， 2025， 41（9）： 1273-1284. doi： 10.3969/j.issn.1006-5725.2025.09.002 . doi: 10.3969/j.issn.1006-5725.2025.09.002
[3]	陈琼，吴卓龙，黄吉炜，免疫治疗在局部进展期肾癌围手术期治疗中的应用进展.中华腔镜泌尿外科杂志（电子版），2025，19（4）： 418-422. doi： 10.3877/cma.j.issn.1674-3253. 2025. 04.004 doi: 10.3877/cma.j.issn.1674-3253. 2025. 04.004
[4]	URRUTIA K， CHEN Y H， TANG J， et al. DNA sequence and lesion-dependent mitochondrial transcription factor A （TFAM）- DNA-binding modulates DNA repair activities and products［J］. Nucleic Acids Res， 2024， 52（22）： 14093-14111.doi： 10.1093/nar/gkae1144 . doi: 10.1093/nar/gkae1144
[5]	SRIVILLIBHUTHUR M， WARDER B N， TOKE N H， et al. TFAM is required for maturation of the fetal and adult intestinal epithelium［J］. Dev Biol， 2018， 439（2）： 92-101. doi： 10.1016/j.ydbio.2018.04.015 . doi: 10.1016/j.ydbio.2018.04.015
[6]	YANG S， HE X， ZHAO J， et al. Mitochondrial transcription factor A plays opposite roles in the initiation and progression of colitis-associated cancer［J］. Cancer Commun （Lond）， 2021， 41（8）： 695-714. doi： 10.1002/cac2.12184 . doi: 10.1002/cac2.12184
[7]	GOLUBICKAITE I， UGENSKIENE R， CEPAITE J， et al. Mitochondria-related TFAM gene variants and their effects on patients with cervical cancer［J］. Biomed Rep， 2021， 15（6）： 106. doi： 10.3892/br.2021.1482 . doi: 10.3892/br.2021.1482
[8]	刘永昌，郝志强，赵玉成，等. 肝细胞肝癌组织中TFAM、PDLIM1表达及与患者临床病理特征和预后的关系［J］. 山东医药， 2023， 63（10）： 6-10.doi： 10.3969/j.issn.1002-266X. 2023.10.002 . doi: 10.3969/j.issn.1002-266X. 2023.10.002
[9]	GUO J， ZHENG L， LIU W， et al. Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer［J］. Cancer Res， 2011， 71（8）： 2978-2987. doi： 10.1158/0008-5472.CAN-10-3482 . doi: 10.1158/0008-5472.CAN-10-3482
[10]	HUANG Q， WU D， ZHAO J， et al. TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis［J］. EMBO J， 2022， 41（11）： e110324. doi： 10.15252/embj.2021110324 . doi: 10.15252/embj.2021110324
[11]	范玲玲，热孜婉古丽·吾布力，卢玲岚，等. TFAM通过调节代谢重编程对卵巢癌细胞化疗耐药的影响及其机制研究［J］. 肿瘤防治研究， 2025， 52（5）： 374-381.doi： 10.3971/j.issn.1000-8578.2025.24.1072 doi: 10.3971/j.issn.1000-8578.2025.24.1072
[12]	赵鑫，吴丹，邢金良，等. 肝癌与癌旁组织间TFAM差异结合蛋白的筛选鉴定及初步功能分析［J］. 空军军医大学学报， 2025， 46（7）： 944-951，960. doi： 10.13276/j.issn.2097-1656. 2025.07.016 . doi: 10.13276/j.issn.2097-1656. 2025.07.016
[13]	肖顺崇，罗汉传，覃俊仕. miR-211通过靶向调控 TFAM抑制人乳腺癌细胞系增殖［J］. 基础医学与临床， 2017， 37（11）： 1590-1595. doi： 10.3969/j.issn.1001-6325.2017.11.018 . doi: 10.3969/j.issn.1001-6325.2017.11.018
[14]	WANG W， SUN H， Ma X， et al. Circ_0002476 regulates cell growth， invasion， and mtDNA damage in non-small cell lung cancer by targeting miR-1182/TFAM axis［J］. Thorac Cancer， 2022， 13（20）： 2867-2878. doi： 10.1111/1759-7714.14631 . doi: 10.1111/1759-7714.14631
[15]	YAO J， ZHOU E， WANG Y， et al. microRNA-200a inhibits cell proliferation by targeting mitochondrial transcription factor A in breast cancer［J］. DNA Cell Biol， 2014， 33（5）： 291-300. doi： 10.1089/dna.2013.2132 . doi: 10.1089/dna.2013.2132
[16]	YAO X， HONG J H， Nargund A M， et al. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-the NF-o activate the NF- NF-A in breast cancer［J］. DNA CelBiol， 2023， 25（5）： 765-777. doi： 10.1038/s41556-023-01122-y . doi: 10.1038/s41556-023-01122-y
[17]	ARAUJO L F， SIENA A D D， PLACE J R， et al. Mitochondrial transcription factor A （TFAM） shapes metabolic and invasion gene signatures in melanoma［J］. Sci Rep， 2018， 8（1）： 14190. doi： 10.1038/s41598-018-31170-6 . doi: 10.1038/s41598-018-31170-6
[18]	QIAO L， RU G， MAO Z， et al. Mitochondrial DNA depletion， mitochondrial mutations and high TFAM expression in hepatocellular carcinoma［J］. Oncotarget， 2017， 8（48）： 84373-84383. doi： 10.18632/oncotarget.21033 . doi: 10.18632/oncotarget.21033
[19]	XIE D， WU X， LAN L， et al. Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics［J］. Oncotarget， 2016， 7（10）： 11609-11624. doi： 10.18632/oncotarget.7018 . doi: 10.18632/oncotarget.7018
[20]	YANG S， HE X， ZHAO J， et al. Mitochondrial transcription factor A plays opposite roles in the initiation and progression of colitis-associated cancer［J］. Cancer Commun （Lond）， 2021， 41（8）：695-714. doi： 10.1002/cac2.12184 . doi: 10.1002/cac2.12184
[21]	WEINBERG F， HAMANAKA R， WHEATON W W， et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity［J］. Proc Natl Acad Sci U S A， 2010， 107（19）： 8788-8793. doi： 10.1073/pnas.1003428107 . doi: 10.1073/pnas.1003428107
[22]	李剑. PHB1通过TFAM参与鼻咽癌细胞的糖代谢的调控的作用与机制研究［D］. 衡阳：南华大学，2022.
[23]	王伟. TFAM调控mtDNA激活cGAS-STING途径在胶质瘤中的作用及机制研究［D］. 苏州：苏州大学，2024.
[24]	许颖，高榴，杨靖瑞，等. 敲低线粒体转录因子A（TFAM）抑制人宫颈癌细胞及骨肉瘤细胞自噬及增殖、侵袭和迁移［J］. 细胞与分子免疫学杂志， 2024， 40（4）： 311-318. doi： 10.13423/j.cnki.cjcmi.009746 . doi: 10.13423/j.cnki.cjcmi.009746
[25]	BOUTROUS R， DOZIER C， DUCOMMUN B. The when and wheres of CDC25 phosphatases［J］. Curr Opin Cell Biol， 2006， 18（2）： 185-191. doi： 10.1016/j.ceb.2006.02.003 . doi: 10.1016/j.ceb.2006.02.003
[26]	LINDQVIST A， KALLSTROM H， LUNDGREN A， et al. Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome［J］. J Cell Biol， 2005， 171（1）： 35-45. doi： 10.1083/jcb.200503066 . doi: 10.1083/jcb.200503066
[27]	WU L， YANG K， GUI Y， et al. Nicotine-upregulated miR-30a arrests cell cycle in G1 phase by directly targeting CCNE2 in human periodontal ligament cells［J］. Biochem Cell Biol， 2020， 98（3）： 354-361. doi： 10.1139/bcb-2019-0156 . doi: 10.1139/bcb-2019-0156
[28]	YU A Q， WANG Z X， WU W， et al. Circular RNA CircCCNB1 sponges micro RNA-449a to inhibit cellular senescence by targeting CCNE2［J］. Aging （Albany NY）， 2019， 11（22）： 10220-10241. doi： 10.18632/aging.102449 . doi: 10.18632/aging.102449
[29]	LI H， FENG H， ZHANG T， et al. CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib［J］. Mol Cancer， 2024， 23（1）： 59. doi： 10.1186/s12943-024-01971-7 . doi: 10.1186/s12943-024-01971-7
[30]	TAO K， LIU J， LIANG J， et al. Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2［J］. Carcinogenesis， 2021，42（8）：1056-1067. doi： 10.1093/carcin/bgab051 . doi: 10.1093/carcin/bgab051